BIOREM Inc.
BRM.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 27.29M | 29.61M | 22.80M | 20.66M | 18.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.29M | 29.61M | 22.80M | 20.66M | 18.61M |
| Cost of Revenue | 19.94M | 20.16M | 15.88M | 14.23M | 13.42M |
| Gross Profit | 7.35M | 9.45M | 6.92M | 6.42M | 5.19M |
| SG&A Expenses | 4.10M | 4.17M | 3.31M | 3.10M | 2.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -32.60K | -3.10K | -- | -- | -- |
| Total Operating Expenses | 24.04M | 24.37M | 19.23M | 17.37M | 16.34M |
| Operating Income | 3.25M | 5.24M | 3.58M | 3.29M | 2.27M |
| Income Before Tax | 3.04M | 5.07M | 3.39M | 2.95M | 2.05M |
| Income Tax Expenses | 807.90K | 1.25M | 801.60K | 686.20K | 451.70K |
| Earnings from Continuing Operations | 2.23 | 3.82 | 2.59 | 2.27 | 1.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.23M | 3.82M | 2.59M | 2.27M | 1.60M |
| EBIT | 3.25M | 5.24M | 3.58M | 3.29M | 2.27M |
| EBITDA | 3.55M | 5.49M | 3.73M | 3.42M | 2.42M |
| EPS Basic | 0.14 | 0.24 | 0.16 | 0.14 | 0.10 |
| Normalized Basic EPS | 0.12 | 0.20 | 0.13 | 0.12 | 0.08 |
| EPS Diluted | 0.10 | 0.21 | 0.15 | 0.13 | 0.09 |
| Normalized Diluted EPS | 0.10 | 0.18 | 0.12 | 0.11 | 0.07 |
| Average Basic Shares Outstanding | 62.85M | 62.95M | 62.85M | 62.85M | 62.85M |
| Average Diluted Shares Outstanding | 70.94M | 72.16M | 71.02M | 68.19M | 65.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |